This approximately 3,000 to 5,000-fold difference in half-life represents the primary pharmacological divergence between the endogenous hormone and its synthetic analog
Some plans cover it with prior authorization, while others have excluded weight loss medications as a category
For Weight Management Sample Dosing : 2.5 mg (0.5mL) each week for weeks 1 to 4 5mg (1 mL) each week for weeks 5 to 8 7.5mg (1.5mL) each week for weeks 9 to 12 10mg (2mL) each week for weeks 13 to 16 12.5mg (2.5mL) each week for weeks 17 to 20 15mg (3mL) each week for weeks 20 and onwards If a dose is missed, administer as soon as possible within 4 days
Clinical trial data suggests comparable GI side effect profiles, though some patients who cannot tolerate one medication do better on the other due to individual receptor sensitivity differences
Alternative maintenance strategies Transitioning from tirzepatide to other GLP-1 agonists represents one alternative maintenance strategy
This can lead to acute liver failure